{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T17:10:53Z","timestamp":1747761053338},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1245\/s10434-020-08896-7","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T15:04:52Z","timestamp":1595516692000},"page":"4786-4794","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ipsilateral and Concurrent Breast Cancer and Atypical Ductal Hyperplasia: Does Atypia Also Need Surgical Excision?"],"prefix":"10.1245","volume":"27","author":[{"given":"Amanda L.","family":"Amin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onalisa D.","family":"Winblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey E.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie L.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"issue":"13","key":"8896_CR1","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJM198903303201302","volume":"320","author":"B Fisher","year":"1989","unstructured":"Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320(13):822\u2013828. https:\/\/doi.org\/10.1056\/nejm198903303201302","journal-title":"N Engl J Med."},{"issue":"16","key":"8896_CR2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233\u20131241. https:\/\/doi.org\/10.1056\/nejmoa022152","journal-title":"N Engl J Med."},{"issue":"1","key":"8896_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2214\/ajr.167.1.8659367","volume":"167","author":"JE Meyer","year":"1996","unstructured":"Meyer JE, Christian RL, Lester SC, Frenna TH, Denison CM, DiPiro PJ, Polder M. Evaluation of nonpalpable solid breast masses with stereotaxic large-needle core biopsy using a dedicated unit. AJR Am J Roentgenol. 1996;167(1):179\u2013182. https:\/\/doi.org\/10.2214\/ajr.167.1.8659367","journal-title":"AJR Am J Roentgenol."},{"key":"8896_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJMsr1407164","volume":"372","author":"LC Hartmann","year":"2020","unstructured":"Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ph D, Ghosh K. Atypical hyperplasia of the breast\u2014risk assessment and management options. N Engl J Med. 2020;372:78\u201389.","journal-title":"N Engl J Med."},{"issue":"1","key":"8896_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.soc.2017.07.011","volume":"27","author":"JM Racz","year":"2018","unstructured":"Racz JM, Degnim AC. When does atypical ductal hyperplasia require surgical excision? Surg Oncol Clin N Am. 2018;27(1):23\u201332. https:\/\/doi.org\/10.1016\/j.soc.2017.07.011","journal-title":"Surg Oncol Clin N Am."},{"key":"8896_CR6","unstructured":"National Comprehensive Cancer Network. Clinical Guidelines, Breast Cancer Risk Reduction, v1. 2019. http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/breast_risk.pdf. Accessed April 16, 2019."},{"issue":"10","key":"8896_CR7","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1245\/s10434-017-5978-0","volume":"24","author":"JM Racz","year":"2017","unstructured":"Racz JM, Carter JM, Degnim AC. Lobular neoplasia and atypical ductal hyperplasia on core biopsy: current surgical management recommendations. Ann Surg Oncol. 2017;24(10):2848\u20132854. https:\/\/doi.org\/10.1245\/s10434-017-5978-0","journal-title":"Ann Surg Oncol."},{"issue":"8","key":"8896_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/00000478-200108000-00005","volume":"25","author":"KA Ely","year":"2001","unstructured":"Ely KA, Carter BA, Jensen RA, Simpson JF, Page DL. Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol. 2001;25(8): 1017\u20131021.","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"8896_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1309\/AJCPGHEJ2R8UYFGP","volume":"131","author":"MJ Wagoner","year":"2009","unstructured":"Wagoner MJ, Laronga C, Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol. 2009;131(1):112\u2013121. https:\/\/doi.org\/10.1309\/ajcpghej2r8uyfgp","journal-title":"Am J Clin Pathol."},{"issue":"1","key":"8896_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.humpath.2010.06.011","volume":"42","author":"KH Allison","year":"2011","unstructured":"Allison KH, Eby PR, Kohr J, Demartini WB, Lehman CD. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade. Hum Pathol. 2011;42(1):41\u201350. https:\/\/doi.org\/10.1016\/j.humpath.2010.06.011","journal-title":"Hum Pathol."},{"issue":"10","key":"8896_CR11","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1245\/s10434-012-2575-0","volume":"19","author":"LJ McGhan","year":"2012","unstructured":"McGhan LJ, Pockaj BA, Wasif N, Giurescu ME, McCullough AE, Gray RJ. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy? Ann Surg Oncol. 2012;19(10):3264\u20133269. https:\/\/doi.org\/10.1245\/s10434-012-2575-0","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"8896_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.amjsurg.2013.05.014","volume":"207","author":"TS Menes","year":"2014","unstructured":"Menes TS, Rosenberg R, Balch S, Jaffer S, Kerlikowske K, Miglioretti DL. Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium. Am J Surg. 2014;207(1):24\u201331. https:\/\/doi.org\/10.1016\/j.amjsurg.2013.05.014","journal-title":"Am J Surg."},{"issue":"3","key":"8896_CR13","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1245\/s10434-010-1127-8","volume":"18","author":"CV Nguyen","year":"2011","unstructured":"Nguyen C V., Albarracin CT, Whitman GJ, Lopez A, Sneige N. Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision. Ann Surg Oncol. 2011;18(3):752\u2013761. https:\/\/doi.org\/10.1245\/s10434-010-1127-8","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"8896_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1309\/0GYV4F2LLJAV4GFN","volume":"119","author":"N Sneige","year":"2003","unstructured":"Sneige N, Lim SC, Whitman GJ, et al. Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications: Considerations for surgical excision. Am J Clin Pathol. 2003;119(2):248\u2013253. https:\/\/doi.org\/10.1309\/0gyv4f2lljav4gfn","journal-title":"Am J Clin Pathol."},{"issue":"9","key":"8896_CR15","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1245\/s10434-013-2989-3","volume":"20","author":"C Uzan","year":"2013","unstructured":"Uzan C, Mazouni C, Ferchiou M, et al. A model to predict the risk of upgrade to malignancy at surgery in atypical breast lesions discovered on percutaneous biopsy specimens. Ann Surg Oncol. 2013;20(9):2850\u20132857. https:\/\/doi.org\/10.1245\/s10434-013-2989-3","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"8896_CR16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.acra.2018.09.010","volume":"26","author":"KE Williams","year":"2019","unstructured":"Williams KE, Amin A, Hill J, et al. Radiologic and pathologic features associated with upgrade of atypical ductal hyperplasia at surgical excision. Acad Radiol. 2019;26(7):893\u2013899. https:\/\/doi.org\/10.1016\/j.acra.2018.09.010","journal-title":"Acad Radiol."},{"issue":"3","key":"8896_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.amjsurg.2007.07.038","volume":"196","author":"C Forgeard","year":"2008","unstructured":"Forgeard C, Benchaib M, Guerin N, et al. Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. Am J Surg. 2008;196(3):339\u2013345. https:\/\/doi.org\/10.1016\/j.amjsurg.2007.07.038","journal-title":"Am J Surg."},{"key":"8896_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.breast.2017.10.003","volume":"37","author":"A Latronico","year":"2018","unstructured":"Latronico A, Nicosia L, Faggian A, et al. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients. Breast. 2018;37:1\u20135. https:\/\/doi.org\/10.1016\/j.breast.2017.10.003","journal-title":"Breast."},{"issue":"11","key":"8896_CR19","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jama.2015.1405","volume":"313","author":"JG Elmore","year":"2015","unstructured":"Elmore JG, Longton GM, Carney PA, et al. Diagnostic concordance among pathologists interpreting breast biopsy specimens. JAMA. 2015;313(11):1122\u20131132. https:\/\/doi.org\/10.1001\/jama.2015.1405","journal-title":"JAMA."},{"issue":"2","key":"8896_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/tbj.12885","volume":"24","author":"A Linsk","year":"2018","unstructured":"Linsk A, Mehta TS, Dialani V, et al. Surgical upgrade rate of breast atypia to malignancy: an academic center\u2019s experience and validation of a predictive model. Breast J. 2018;24(2):115\u2013119. https:\/\/doi.org\/10.1111\/tbj.12885","journal-title":"Breast J."},{"issue":"2","key":"8896_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10549-017-4253-1","volume":"164","author":"A Pe\u00f1a","year":"2017","unstructured":"Pe\u00f1a A, Shah SS, Fazzio RT, et al. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia. Breast Cancer Res Treat. 2017;164(2):295\u2013304. https:\/\/doi.org\/10.1007\/s10549-017-4253-1","journal-title":"Breast Cancer Res Treat."},{"issue":"6","key":"8896_CR22","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1016\/S1470-2045(13)70598-9","volume":"15","author":"LJ Esserman","year":"2014","unstructured":"Esserman LJ, Thompson IM, Reid B, et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol. 2014;15(6): e234\u2013e242 https:\/\/doi.org\/10.1016\/s1470-2045(13)70598-9","journal-title":"Lancet Oncol."},{"issue":"3","key":"8896_CR23","doi-asserted-by":"publisher","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang ES, Hyslop T, Lynch T, et al. The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open. 2019;9(3):e026797. https:\/\/doi.org\/10.1136\/bmjopen-2018-026797","journal-title":"BMJ Open."},{"issue":"6","key":"8896_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.21037\/gs.2018.07.01","volume":"7","author":"ZE Winters","year":"2018","unstructured":"Winters ZE, Bernaudo L. Evaluating the current evidence to support therapeutic mammoplasty or breast-conserving surgery as an alternative to mastectomy in the treatment of multifocal and multicentric breast cancers. Gland Surg. 2018;7(6):525\u2013535. https:\/\/doi.org\/10.21037\/gs.2018.07.01","journal-title":"Gland Surg."},{"issue":"4","key":"8896_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/bjs5.53","volume":"2","author":"ZE Winters","year":"2018","unstructured":"Winters ZE, Horsnell J, Elvers KT, et al. Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers. BJS Open. 2018;2(4):162\u2013174. https:\/\/doi.org\/10.1002\/bjs5.53","journal-title":"BJS Open."},{"issue":"10","key":"8896_CR26","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1245\/s10434-018-6583-6","volume":"25","author":"KM Rosenkranz","year":"2018","unstructured":"Rosenkranz KM, Ballman K, McCall L, et al. The feasibility of breast-conserving surgery for multiple ipsilateral breast cancer: an initial report from ACOSOG Z11102 (Alliance) Trial. Ann Surg Oncol. 2018;25(10):2858\u20132866. https:\/\/doi.org\/10.1245\/s10434-018-6583-6","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"8896_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1245\/s10434-016-5512-9","volume":"24","author":"RS Menen","year":"2017","unstructured":"Menen RS, Ganesan N, Bevers T, et al. Long-term safety of observation in selected women following core biopsy diagnosis of atypical ductal hyperplasia. Ann Surg Oncol. 2017;24(1):70\u201376. https:\/\/doi.org\/10.1245\/s10434-016-5512-9","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08896-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08896-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08896-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T23:39:41Z","timestamp":1626997181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08896-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["8896"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08896-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Amanda L. Amin, Fang Fan, Onalisa D. Winblad, Kelsey E. Larson, and Jamie L. Wagner have no commercial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}